☰

Ilan Volovitz, Ph.D. - Publications

Affiliations: 
2006 Weizmann Institute of Science, Rehovot, Israel 
Area:
Immunology
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Gershon R, Polevikov A, Karepov Y, Shenkar A, Ben-Horin I, Alter Regev T, Dror-Levinsky M, Lipczyc K, Gasri-Plotnitsky L, Diamant G, Shapira N, Bensimhon B, Hagai A, Shahar T, Grossman R, ... ... Volovitz I, et al. `Frequencies of four Tumor-infiltrating lymphocytes potently predict survival in glioblastoma, an immune desert. Neuro-Oncology. PMID 37870293 DOI: 10.1093/neuonc/noad204  0.413
2023 Dror Levinsky M, Brenner B, Yalon M, Levi Z, Livneh Z, Cohen Z, Paz-Elizur T, Grossman R, Ram Z, Volovitz I. A Highly Sensitive Flow Cytometric Approach to Detect Rare Antigen-Specific T Cells: Development and Comparison to Standard Monitoring Tools. Cancers. 15. PMID 36765532 DOI: 10.3390/cancers15030574  0.364
2021 Diamant G, Simchony Goldman H, Gasri Plotnitsky L, Roitman M, Shiloach T, Globerson-Levin A, Eshhar Z, Haim O, Pencovich N, Grossman R, Ram Z, Volovitz I. T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields. Journal of Immunology (Baltimore, Md. : 1950). PMID 34215656 DOI: 10.4049/jimmunol.2100100  0.356
2019 Simchony H, Diamant D, Ram Z, Volovitz I. Evaluation of the Compatibility of Electric Tumor Treating Fields with Key Anti-tumoral T-Cell Functions. The Israel Medical Association Journal : Imaj. 21: 503. PMID 31507132  0.414
2018 Volovitz I, Diamant G, Roitman M, Shapira N, Hagai R, Bensimhon B, Lustgarten M, Grossman R, Ram Z. Abstract 2272: Identification of predictive biomarkers for immunotherapy of brain and solid tumors by studying inter-cellular immune networks Cancer Research. 78: 2272-2272. DOI: 10.1158/1538-7445.Am2018-2272  0.519
2018 Diamant G, Simchony H, Shiloach T, Globerson-Levin A, Eshhar Z, Grossman R, Ram Z, Volovitz I. IMMU-71. EVALUATING THE COMPATIBILITY OF TUMOR TREATING ELECTRIC FIELDS WITH KEY ANTI-TUMORAL T CELL FUNCTIONS Neuro-Oncology. 20: vi137-vi138. DOI: 10.1093/Neuonc/Noy148.574  0.465
2017 Ben-Horin I, Shenkar A, Alter-Regev T, Diamant G, Shapira N, Ram Z, Volovitz I. Identification of subsets of tumor infiltrating lymphocytes in primary brain tumors using multi-color panel flow cytometry Annals of Oncology. 28: xi25. DOI: 10.1093/annonc/mdx711.068  0.324
2016 Volovitz I, Melzer S, Amar S, Bocsi J, Bloch M, Efroni S, Ram Z, Tárnok A. Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools. International Reviews of Immunology. 35: 116-35. PMID 27007190 DOI: 10.3109/08830185.2015.1096935  0.483
2016 Diamant G, Ram Z, Volovitz I. Imst-30. Evaluating The In-Vitro Effects Of Tumor-Treating Fields On T-Cell Responses Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.386  0.467
2016 Grossman R, Volovitz I, Shapira N, Ram Z. Atim-12. A Method To Classify Human Astrocytoma Cell Using Multiparametric Flow Cytometry: A Step Towards Single-Cell Molecular Pathology Of Solid Tumors Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.077  0.411
2011 Volovitz I, Marmor Y, Azulay M, Machlenkin A, Goldberger O, Mor F, Slavin S, Ram Z, Cohen IR, Eisenbach L. Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 5452-62. PMID 21998458 DOI: 10.4049/Jimmunol.1003946  0.745
2011 Kovjazin R, Volovitz I, Kundel Y, Rosenbaum E, Medalia G, Horn G, Smorodinsky NI, Brenner B, Carmon L. ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors. Vaccine. 29: 4676-86. PMID 21570434 DOI: 10.1016/j.vaccine.2011.04.103  0.427
2011 Kovjazin R, Volovitz I, Daon Y, Vider-Shalit T, Azran R, Tsaban L, Carmon L, Louzoun Y. Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development. Molecular Immunology. 48: 1009-18. PMID 21316766 DOI: 10.1016/j.molimm.2011.01.006  0.307
2010 Volovitz I, Marmor Y, Mor F, Flügel A, Odoardi F, Eisenbach L, Cohen IR. T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP-transduced, encephalitogenic T cells. Journal of Autoimmunity. 35: 135-44. PMID 20580204 DOI: 10.1016/J.Jaut.2010.05.003  0.641
2009 Volovitz I, Mor F, Machlenkin A, Machlenkin A, Goldberger O, Marmor Y, Eisenbach L, Cohen IR, Cohen I. T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis. Immunology. 128: 92-102. PMID 19689739 DOI: 10.1111/J.1365-2567.2009.03074.X  0.718
2008 Goldberger O, Volovitz I, Machlenkin A, Vadai E, Tzehoval E, Eisenbach L. Exuberated numbers of tumor-specific T cells result in tumor escape. Cancer Research. 68: 3450-7. PMID 18451173 DOI: 10.1158/0008-5472.Can-07-5006  0.755
2007 Machlenkin A, Azriel-Rosenfeld R, Volovitz I, Vadai E, Lev A, Paz A, Goldberger O, Reiter Y, Tzehoval E, Benhar I, Eisenbach L. Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice. Cancer Immunology, Immunotherapy : Cii. 56: 217-26. PMID 16738849 DOI: 10.1007/S00262-006-0184-0  0.726
2005 Machlenkin A, Paz A, Bar Haim E, Goldberger O, Finkel E, Tirosh B, Volovitz I, Vadai E, Lugassy G, Cytron S, Lemonnier F, Tzehoval E, Eisenbach L. Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy. Cancer Research. 65: 6435-42. PMID 16024648 DOI: 10.1158/0008-5472.Can-05-0133  0.718
2005 Machlenkin A, Goldberger O, Tirosh B, Paz A, Volovitz I, Bar-Haim E, Lee SH, Vadai E, Tzehoval E, Eisenbach L. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4955-61. PMID 16000595 DOI: 10.1158/1078-0432.Ccr-04-2422  0.737
2004 Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Cancer Gene Therapy. 11: 237-48. PMID 14739939 DOI: 10.1038/Sj.Cgt.7700678  0.728
2004 Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood. 103: 1770-8. PMID 14604968 DOI: 10.1182/Blood-2003-06-2114  0.603
Show low-probability matches.